Thiarabine

N/A

Report date: 2022/12/07 18:11:11
NME

Base Information

Drug NameThiarabine
Drug Alias NameT-araCVP-700VP-701GS-7836SR-9025 +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionImmunomodulatorsDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsHematologic NeoplasmsLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbeona Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer CenterAbeona Therapeutics IncOsi Pharmaceuticals
Active IndicationsN/A
Inactive IndicationsHematologic NeoplasmsLeukemia

Other Information

ATC CodeN/A
Related LinksN/A